(Q40791120)

23 September 2017

1 reference

title

Pharmacokinetic optimisation of oral antifungal therapy (English)

1 reference

23 September 2017

1 reference

M Schäfer-Korting

1

1 reference

23 September 2017

1 October 1993

1 reference

Clinical Pharmacokinetics

23 September 2017

1 reference

23 September 2017

25

1 reference

23 September 2017

4

1 reference

23 September 2017

329-341

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199325040-00006

23 September 2017

0 references

cites work

Interaction of Fluconazole with Ciclosporin A

1 reference

12 December 2020

Drug interactions with fluconazole

1 reference

12 December 2020

Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Pharmacokinetics of amphotericin B and flucytosine

1 reference

12 December 2020

Candidosis of the oral cavity. Recognition and management

1 reference

12 December 2020

Treatment of two cases of cryptococcal meningitis with fluconazole

1 reference

12 December 2020

Griseofulvin levels in stratum corneum. Study after oral administration in man

1 reference

12 December 2020

Effects of ranitidine and sucralfate on ketoconazole bioavailability

1 reference

12 December 2020

Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro

1 reference

12 December 2020

Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections

1 reference

12 December 2020

Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance

1 reference

12 December 2020

Effect of feeding on bioavailability of griseofulvin in children.

1 reference

12 December 2020

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

12 December 2020

Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat

1 reference

12 December 2020

Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopy

1 reference

12 December 2020

Effect of fluconazole on the disposition of phenytoin

1 reference

12 December 2020

1 reference

12 December 2020

Diseases and drugs but not food decrease ketoconazole 'bioavailability'.

1 reference

12 December 2020

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits

1 reference

12 December 2020

Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora

1 reference

12 December 2020

Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin

1 reference

12 December 2020

Itraconazole pharmacokinetics in patients with renal dysfunction

1 reference

12 December 2020

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of fluconazole in humans

1 reference

12 December 2020

Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis

1 reference

12 December 2020

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

12 December 2020

Clinical pharmacokinetics of terbinafine (Lamisil).

1 reference

12 December 2020

The clinical pharmacokinetics of itraconazole: an overview

1 reference

12 December 2020

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

1 reference

12 December 2020

Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits

1 reference

12 December 2020

Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge

1 reference

12 December 2020

Individualizing treatment of vaginal candidiasis

1 reference

12 December 2020

Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Fluconazole levels in human epidermis and blister fluid

1 reference

12 December 2020

Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients

1 reference

12 December 2020

Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat

1 reference

12 December 2020

Retention of ketoconazole in the skin following oral treatment

1 reference

12 December 2020

Interaction between cyclosporine and fluconazole in renal allograft recipients

1 reference

12 December 2020

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

12 December 2020

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates

1 reference

12 December 2020

5-Fluorocytosine kinetics in patients with acute renal failure undergoing continuous hemofiltration

1 reference

12 December 2020

Absorption, Distribution, Metabolism, and Excretion of Griseofulvin in Man and Animals

1 reference

12 December 2020

Skin blister fluid levels of ketoconazole during repetitive administration in healthy man.

1 reference

12 December 2020

Drug interactions with fluconazole

1 reference

12 December 2020

Itraconazole Compared with Griseofulvin in the Treatment of Tinea corporis/cruris and Tinea pedis/manus: An Interpretation of the Clinical Results of all Completed Double-Blind Studies with Respect to the Pharmacokinetic Profile

1 reference

12 December 2020

Single-dose oral fluconazole in the treatment of vaginal candidosis

1 reference

12 December 2020

Diffusion of 5-fluorocytosine in bronchial secretions in patients with respiratory insufficiency

1 reference

12 December 2020

Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa

1 reference

12 December 2020

Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis

1 reference

12 December 2020

Transient increase in plasma quinidine concentrations during ketoconazole-quinidine therapy

1 reference

12 December 2020

Orally administered ketoconazole: route of delivery to the human stratum corneum

1 reference

12 December 2020

Hepatic reactions associated with ketoconazole in the United Kingdom

1 reference

12 December 2020

Torsades de pointes occurring in association with terfenadine use

1 reference

12 December 2020

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

1 reference

12 December 2020

Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects

1 reference

12 December 2020

Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study

1 reference

12 December 2020

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

12 December 2020

Clinical pharmacokinetics of systemic antifungal drugs

1 reference

12 December 2020

Clinical pharmacokinetics of ketoconazole

1 reference

12 December 2020

Impact of ketoconazole on the metabolism of prednisolone

1 reference

12 December 2020

Human plasma and skin blister fluid levels of griseofulvin after its repeated administration

1 reference

12 December 2020

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

1 reference

12 December 2020

Pharmacokinetic profile of orally administered itraconazole in human skin

1 reference

12 December 2020

Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration

1 reference

12 December 2020

Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis

1 reference

12 December 2020

Plasma concentrations of griseofulvin in healthy volunteers and out-patients treated for onychomycosis

1 reference

12 December 2020

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

1 reference

12 December 2020

Influence of plasma protein binding on the brain uptake of an antifungal agent, terbinafine, in rats

1 reference

12 December 2020

Ketoconazole concentrations in human skin blister fluid and plasma

1 reference

12 December 2020

Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.

1 reference

12 December 2020

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

1 reference

12 December 2020

Comparative bioavailability of a microsize and ultramicrosize griseofulvin formulation in man

1 reference

12 December 2020

Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone

1 reference

12 December 2020

10.2165/00003088-199325040-00006

Identifiers

DOI

1 reference

PubMed ID

8261715

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

8261715